- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (1799)
- Timeline of Article Publication (18)
- Authors Evaluation (12)
- Article Quality Tracking (1)
- Reference Citation Analysis (7)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3388)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 15, 2025 (publication date) through Jul 28, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu FD, Zhou HF, Yang W, Zhu D, Wu BF, Shi HB, Liu S, Zhou WZ. Transarterial chemoembolization combined with lenvatinib and sintilimab vs lenvatinib alone in intermediate-advanced hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(1): 96267 [PMID: 39817120 DOI: 10.4251/wjgo.v17.i1.96267] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i1/96267.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Yongfa Lei, Xiaotian Liang, Hua Zhu, Jin Wang, Xiaochen Zhang, Siliang Duan, Weiming Liang. Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: a systematic review and meta-analysis. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1586914
|